FindTrial
Sign In

Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging

Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029779
Enrollment
Unknown
Registered
2020-02-13
Start date
2020-02-14
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

gas&#32
function&#32
blood&#32
Gold Standard:Guidelines for novel coronavirus pneumonia (fifth edition)
Index test:Diagnosis&#32
model&#32
based&#32
on&#32
Artificial&#32
Intelligence&#32
(Epidemiological&#32
history,&#32
clinical&#32
information,&#32
laboratory&#32
examination,&#32
hospitalization&#32
profile,&#32
pulmonary&#32

Sponsors

Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed by nucleic acid and/or genetic test in Wuxi (later expanded to southern Jiangsu and Jiangsu Province) with novel coronavirus pneumonia, and other types of viral pneumonia confirmed by nucleic acid and/or genetic testing and/or pathological testing, cases of mycoplasma pneumonia, fungal pneumonia, hypersensitivity pneumonia, and mixed pulmonary infections with similar imaging findings that need to be differentiated from novel coronavirus pneumonia.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Chest CT findings;Epidemiological history;Laboratory examination;Pulmonary function test;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactXiangming Fang

Wuxi People's Hospital

xiangming_fang@njmu.edu.cn+86 13861779030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026